Bone Marrow TransplantationBone MarrowStem CellsTransplantation, HomologousBone Marrow CellsAdult Stem CellsHematopoietic Stem CellsEmbryonic Stem CellsGraft vs Host DiseaseTransplantation, AutologousCell DifferentiationHematopoietic Stem Cell TransplantationWhole-Body IrradiationBone and BonesTransplantation ConditioningStem Cell TransplantationAnemia, AplasticLeukemiaTransplantation ChimeraLiver TransplantationGraft SurvivalTissue DonorsBusulfanBone Marrow PurgingHistocompatibility TestingCyclophosphamideHistocompatibilityHematopoiesisTransplantation, IsogeneicMice, Inbred C57BLCombined Modality TherapyBone Marrow DiseasesKidney TransplantationRecurrenceTime FactorsRadiation ChimeraTreatment OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteHematologic NeoplasmsRemission InductionBone Marrow ExaminationImmunosuppressive AgentsCell ProliferationPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft RejectionHepatic Veno-Occlusive DiseaseColony-Forming Units AssaySurvival AnalysisBone RemodelingBone Marrow NeoplasmsFlow CytometryLeukemia, MyeloidTransplantation ImmunologyRetrospective StudiesGraft vs Host ReactionLymphoma, Non-HodgkinImmunosuppressionCells, CulturedMesenchymal Stem Cell TransplantationLymphocyte DepletionAntineoplastic Combined Chemotherapy ProtocolsChimeraAcute DiseaseLeukocyte TransfusionT-LymphocytesHeart TransplantationSevere Combined ImmunodeficiencySurvival RateMyelodysplastic SyndromesHLA AntigensPluripotent Stem CellsBreast NeoplasmsFollow-Up StudiesMice, Inbred BALB CStem Cell NicheHematologic DiseasesCell LineageMesenchymal Stromal CellsAntineoplastic AgentsNeoplasmsLung TransplantationActuarial AnalysisCyclosporineDisease-Free SurvivalLymphocyte TransfusionBone DensityAntigens, CD34Granulocyte Colony-Stimulating FactorPrognosisApoptosisCell SeparationCell SurvivalHematopoietic Stem Cell MobilizationCell DivisionCarmustineNuclear FamilyCell Line, TumorTransplantation, HeterologousEtoposide